Surgical Treatment of Advanced Melanoma

Clinics in Plastic Surgery

Volumn 37, Issue 1, 2010, Pages 161-168

  Hussussian, Christopher J ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Metastatic melanoma; Metastectomy; Outcomes; Resection; Surgery

Indexed keywords

CORTICOSTEROID; DEXAMETHASONE;

ADRENAL METASTASIS; BONE METASTASIS; BRAIN METASTASIS; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CLINICAL EFFECTIVENESS; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DRUG EFFICACY; LIVER METASTASIS; LUNG METASTASIS; LYMPH NODE METASTASIS; MELANOMA; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PATIENT SELECTION; PREOPERATIVE EVALUATION; PROGNOSIS; REVIEW; SKIN METASTASIS; SOFT TISSUE METASTASIS; SURGICAL TECHNIQUE; SURVIVAL RATE; SURVIVAL TIME; TREATMENT INDICATION; TUMOR BIOPSY; VISCERAL METASTASIS;

HUMANS; MELANOMA; PALLIATIVE CARE; PATIENT SELECTION; SKIN NEOPLASMS; SURVIVAL RATE;

EID: 70449374879     PISSN: 00941298     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cps.2009.07.004     Document Type: Review

References (58)

1. Balch C.M., Soong S.J., Gershenwald J.E., et al. Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol 19 16 (2001) 3622-3634
2. Morton D.L., Mozzillo N., Thompson J.F., et al. An international, randomized, phase III trial of bacillus Calmette-Guérin (BCG) plus allogeneic melanoma vaccine (MCV) or placebo after complete resection of melanoma metastatic to regional or distant sites. [abstract]. J Clin Oncol 25 18S (2007) 474s
3. Tagawa S., Cheung E., Banta W., et al. Survival analysis after resection of metastatic disease followed by peptide vaccines in patients with stage IV melanoma. Cancer 106 6 (2006) 1353-1357
4. Mosca P.J., Teicher E., Nair S., et al. Can surgeons improve survival in stage IV melanoma?. J Surg Oncol 97 5 (2008) 462-468
5. Balch C.M., Soong S.J., Murad T.M., et al. A multifactorial analysis of melanoma. IV. Prognostic factors in 200 melanoma patients with distant metastases (stage III). J Clin Oncol 1 2 (1983) 126-134
6. Barth A., Wanek L.A., and Morton D.L. Prognostic factors in 1,521 melanoma patients with distant metastases. J Am Coll Surg 181 3 (1995) 193-201
7. Martinez S., and Young S. A rational surgical approach to the treatment of distant melanoma metastases. Cancer Treat Rev 34 (2008) 614-620
8. Essner R., Lee J.H., Wanek L.A., et al. Contemporary surgical treatment of advanced-stage melanoma. Arch Surg 139 9 (2004) 961-966 [discussion: 966-7]
9. Hofmann U., Szedlak M., Rittgen W., et al. Primary staging and follow-up in melanoma patients-monocenter evaluation of methods, costs and patient survival. Br J Cancer 87 2 (2002) 151-157
10. Tsao H., Feldman M., Fullerton J.E., et al. Early detection of asymptomatic pulmonary melanoma metastases by routine chest radiographs is not associated with improved survival. Arch Dermatol 140 1 (2004) 67-70
11. Dalrymple-Hay M.J., Rome P.D., Kennedy C., et al. Pulmonary metastatic melanoma-the survival benefit associated with positron emission tomography scanning. Eur J Cardiothorac Surg 21 4 (2002) 611-614 [discussion: 614-5]
12. Voit C., Schoengen A., Schwürzer-Voit M., et al. The role of ultrasound in detection and management of regional disease in melanoma patients. Semin Oncol 29 4 (2002) 353-360
13. Garbe C., Paul A., Kohler-Späth H., et al. Prospective evaluation of a follow-up schedule in cutaneous melanoma patients: recommendations for an effective follow-up strategy. J Clin Oncol 21 3 (2003) 520-529
14. Finkelstein S., Carrasquillo J., Hoffman J., et al. A prospective analysis of positron emission tomography and conventional imaging for detection of stage IV metastatic melanoma in patients undergoing metastasectomy. Ann Surg Oncol 11 8 (2004) 731-738
15. Horn J., Lock-Andersen J., Sjøstrand H., et al. Routine use of FDG-PET scans in melanoma patients with positive sentinel node biopsy. Eur J Nucl Med Mol Imaging 33 8 (2006) 887-892
16. Akcali C., Zincirkeser S., Erbagcý Z., et al. Detection of metastases in patients with cutaneous melanoma using FDG-PET/CT. J Int Med Res 35 4 (2007) 547-553
17. Pfannenberg C., Aschoff P., Schanz S., et al. Prospective comparison of 18F-fluorodeoxyglucose positron emission tomography/computed tomography and whole-body magnetic resonance imaging in staging of advanced malignant melanoma. Eur J Cancer 43 3 (2007) 557-564
18. Balch C., Buzaid A., Soong S.J., et al. New TNM melanoma staging system: linking biology and natural history to clinical outcomes. Semin Surg Oncol 21 1 (2003) 43-52
19. Balch C.M., Buzaid A.C., Soong S.J., et al. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol 19 16 (2001) 3635-3648
20. Markowitz J.S., Cosimi L.A., Carey R.W., et al. Prognosis after initial recurrence of cutaneous melanoma. Arch Surg 126 6 (1991) 703-707 [discussion: 707-8]
21. Gadd M.A., and Coit D.G. Recurrence patterns and outcome in 1019 patients undergoing axillary or inguinal lymphadenectomy for melanoma. Arch Surg 127 12 (1992) 1412-1416
22. Karakousis C.P., Velez A., Driscoll D.L., et al. Metastasectomy in malignant melanoma. Surgery 115 3 (1994) 295-302
23. Meyer T., Merkel S., Goehl J., et al. Surgical therapy for distant metastases of malignant melanoma. Cancer 89 9 (2000) 1983-1991
24. Bowen G.M., Chang A.E., Lowe L., et al. Solitary melanoma confined to the dermal and/or subcutaneous tissue: evidence for revisiting the staging classification. Arch Dermatol 136 11 (2000) 1397-1399
25. Kroon B.B., Noorda E.M., Vrouenraets B.C., et al. Isolated limb perfusion for melanoma. Surg Oncol Clin N Am 17 4 (2008) 785-794 viii-ix
26. Sanki A., Kam P.C., and Thompson J. Long-term results of hyperthermic, isolated limb perfusion for melanoma: a reflection of tumor biology. Ann Surg 245 4 (2007) 591-596
27. Gorenstein L.A., Putnam J.B., Natarajan G., et al. Improved survival after resection of pulmonary metastases from malignant melanoma. Ann Thorac Surg 52 2 (1991) 204-210
28. Harpole D.H., Johnson C.M., Wolfe W.G., et al. Analysis of 945 cases of pulmonary metastatic melanoma. J Thorac Cardiovasc Surg 103 4 (1992) 743-748 [discussion: 748-50]
29. Karp N.S., Boyd A., DePan H.J., et al. Thoracotomy for metastatic malignant melanoma of the lung. Surgery 107 3 (1990) 256-261
30. Tafra L., Dale P.S., Wanek L.A., et al. Resection and adjuvant immunotherapy for melanoma metastatic to the lung and thorax. J Thorac Cardiovasc Surg 110 1 (1995) 119-128 [discussion: 129]
31. Leo F., Cagini L., Rocmans P., et al. Lung metastases from melanoma: when is surgical treatment warranted?. Br J Cancer 83 5 (2000) 569-572
32. Andrews S., Robinson L., Cantor A., et al. Survival after surgical resection of isolated pulmonary metastases from malignant melanoma. Cancer Control 13 3 (2006) 218-223
33. Neuman H., Patel A., Hanlon C., et al. Stage-IV melanoma and pulmonary metastases: factors predictive of survival. Ann Surg Oncol 14 10 (2007) 2847-2853
34. Ollila D.W., Stern S.L., and Morton D.L. Tumor doubling time: a selection factor for pulmonary resection of metastatic melanoma. J Surg Oncol 69 4 (1998) 206-211
35. Patel J.K., Didolkar M.S., Pickren J.W., et al. Metastatic pattern of malignant melanoma. A study of 216 autopsy cases. Am J Surg 135 6 (1978) 807-810
36. Reintgen D.S., Thompson W., Garbutt J., et al. Radiologic, endoscopic, and surgical considerations of melanoma metastatic to the gastrointestinal tract. Surgery 95 6 (1984) 635-639
37. Ricaniadis N., Konstadoulakis M.M., Walsh D., et al. Gastrointestinal metastases from malignant melanoma. Surg Oncol 4 2 (1995) 105-110
38. Ollila D.W., Essner R., Wanek L.A., et al. Surgical resection for melanoma metastatic to the gastrointestinal tract. Arch Surg 131 9 (1996) 975-979 979-80
39. Agrawal S., Yao T.J., and Coit D.G. Surgery for melanoma metastatic to the gastrointestinal tract. Ann Surg Oncol 6 4 (1999) 336-344
40. Gutman H., Hess K., Kokotsakis J., et al. Surgery for abdominal metastases of cutaneous melanoma. World J Surg 25 6 (2001) 750-758
41. Wood T.F., DiFronzo L.A., Rose D.M., et al. Does complete resection of melanoma metastatic to solid intra-abdominal organs improve survival?. Ann Surg Oncol 8 8 (2001) 658-662
42. Branum G.D., Epstein R.E., Leight G.S., et al. The role of resection in the management of melanoma metastatic to the adrenal gland. Surgery 109 2 (1991) 127-131
43. Haigh P.I., Essner R., Wardlaw J.C., et al. Long-term survival after complete resection of melanoma metastatic to the adrenal gland. Ann Surg Oncol 6 7 (1999) 633-639
44. Rose D.M., Essner R., Hughes T.M., et al. Surgical resection for metastatic melanoma to the liver: the John Wayne Cancer Institute and Sydney Melanoma Unit experience. Arch Surg 136 8 (2001) 950-955
45. Mendez I.M., and Del Maestro R.F. Cerebral metastases from malignant melanoma. Can J Neurol Sci 15 2 (1988) 119-123
46. Tarhini A.A., and Agarwala S.S. Management of brain metastases in patients with melanoma. Curr Opin Oncol 16 2 (2004) 161-166
47. Patchell R. Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial. JAMA 280 17 (1998) 1485-1489
48. Skibber J.M., Soong S.J., Austin L., et al. Cranial irradiation after surgical excision of brain metastases in melanoma patients. Ann Surg Oncol 3 2 (1996) 118-123
49. Sampson J.H., Carter J.H., Friedman A.H., et al. Demographics, prognosis, and therapy in 702 patients with brain metastases from malignant melanoma. J Neurosurg 88 1 (1998) 11-20
50. Zacest A.C., Besser M., Stevens G., et al. Surgical management of cerebral metastases from melanoma: outcome in 147 patients treated at a single institution over two decades. J Neurosurg 96 3 (2002) 552-558
51. McWilliams R.R., Brown P.D., Buckner J.C., et al. Treatment of brain metastases from melanoma. Mayo Clin Proc 78 12 (2003) 1529-1536
52. Wroński M., and Arbit E. Surgical treatment of brain metastases from melanoma: a retrospective study of 91 patients. J Neurosurg 93 1 (2000) 9-18
53. Ballo M.T., and Ang K.K. Radiation therapy for malignant melanoma. Surg Clin North Am 83 2 (2003) 323-342
54. Yu C., Chen J.C., Apuzzo M.L., et al. Metastatic melanoma to the brain: prognostic factors after gamma knife radiosurgery. Int J Radiat Oncol Biol Phys 52 5 (2002) 1277-1287
55. Radbill A.E., Fiveash J.F., Falkenberg E.T., et al. Initial treatment of melanoma brain metastases using gamma knife radiosurgery: an evaluation of efficacy and toxicity. Cancer 101 4 (2004) 825-833
56. Mathieu D., Kondziolka D., Cooper P.B., et al. Gamma knife radiosurgery in the management of malignant melanoma brain metastases. Neurosurgery 60 3 (2007) 471-481 [discussion: 481-2]
57. Samlowski W., Watson G., Wang M., et al. Multimodality treatment of melanoma brain metastases incorporating stereotactic radiosurgery (SRS). Cancer 109 9 (2007) 1855-1862
58. DeBoer D.K., Schwartz H.S., Thelman S., et al. Heterogeneous survival rates for isolated skeletal metastases from melanoma. Clin Orthop Relat Res 323 (1996) 277-283